Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL28791682 | 0.95 | CA5A (0.60) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL921114 | 0.95 | CA5A (0.60) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL126226 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL3280249 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL924013 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL2313307 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL28463255 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL2302635 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL21635099 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 | |
| Sulfuric Acid SCHEMBL4529065 | 0.91 | CA5A (0.55) | CA5ACA5BTSHRCA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105916487-A | Peptide composition and uses thereof | 米尼翁大学 | 2016-08-31 | — | — | CN | disclosed |
| US-8097602-B1 | Method of treating body insect infestation | HOST PHARMACEUTICALS, LLC (US) | 2012-01-17 | — | — | US | disclosed |
| EP-2337544-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | Living Proof, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| WO-2009105617-A1 | METHOD OF TREATING BODY INSECT INFESTATION | HOST PHARMACEUTICALS, LLC (US) | 2009-08-27 | — | — | WO | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| US-RE40534-E1 | Clear conditioning detersive compositions containing polysiloxanes with at least one cyclic side chain | CHEMSIL SILICONES, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-6642194-B2 | Clear hair shampoo composition comprising detersive component, emulsifier component and polysiloxane component in amount effective as hair conditioner | CHEMSIL SILICONES, INC. | 2003-11-04 | — | — | US | disclosed |
| US-6605577-B1 | Having a hindered amine group; hair shampoo | CHEMSIL SILICONES, INC. | 2003-08-12 | — | — | US | disclosed |
| US-20030134760-A1 | Clear conditioning detersive compositions and methods for making the same | CHEMSIL SILICONES, INC. | 2003-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | CA5A 1314/4885CA5B 1071/4885TSHR 2597/4885 |
| US-20030134760-A1 | Clear conditioning detersive compositions and methods for making the same | ASH2L, CD47, THOC2 | CA5A 2170/4885CA5B 2529/4885TSHR 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.